Attachment L-8 MMC Sample File.xlsx

XLSX spreadsheet 11 KB Posted

Attached to
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5)
Solicitation number
HT940220R0002
Issued by

About this file

Written by GovTribe AI ·

This notice provides a draft request for proposals (RFP) for pharmacy services under the TRICARE Pharmacy Program, 5th Generation (TPharm5). The Defense Health Agency (DHA) anticipates an 18-month base period for transition, seven 1-year option periods for health care delivery, and a potential 6-month extension, for a total potential period of performance of 9 years. The draft RFP includes Sections B through M and attachments in Sections L and J. DHA is seeking industry feedback on requirements and approach by January 17, 2020. DHA will host an informational session on December 11, 2019 and post slides and information provided. DHA estimates a formal RFP may be issued in mid-2020. The notice identifies sections on statements of objectives, specialty pharmacy, retail network access, compounded medications, care coordination, patient safety notifications, and quality control for particular review and comment.

View the file

Other files

File Type Posted
DSADHA_SSVTemplate_20170101.pdf PDF
QA CAS Applicability Specific Clauses (May 15 2020).pdf PDF
Responses to Industry on Revised Draft Section C 20200504.pdf PDF
TPharm5 - Overview of Changes to Draft Section C.DOCX DOCX document
TPharm5 Section C Draft RFP2 2020-4-6.docx DOCX document
DHA Responses to Industry on Draft RFP 20200318.pdf PDF
TPharm5 Draft RFP Info Session 20191211.pdf PDF
Data Pkg 2 - Retail Utilization by Drug.xlsx XLSX spreadsheet
Attachment L-9.8 PA_ST_QL List.XLSX XLSX spreadsheet
Data Pkg 15 IHS_Pharmacy_Claims_Volume_2017_&_2018.xlsx XLSX spreadsheet
Data Pkg 3 TRICARE Retail Pharmacy Claim Volume.xlsx XLSX spreadsheet
Attachment L-9.4 Covered OTC List - MHS GENESIS.xlsx XLSX spreadsheet
Attachment L-10 Small Business Participation Plan.docx DOCX document
TPharm5 Draft Section J 20191127.docx DOCX document
Data Pkg 8 Mail and Retail Monthly Utilizers.xlsx XLSX spreadsheet
Attachment J-1 Definitions.DOCX DOCX document
TPharm5 Draft Section M 20191202.docx DOCX document
Attachment L-9.6 Self-Admin Injectables List.xlsx XLSX spreadsheet
Attachment L-19 Past Performance Questionnaire Template Tab F 20191120.docx DOCX document
Attachment L-3 Specialty Reimbursement for Use in Determining Incentiv....docx DOCX document
Attachment L-9 Benefit Design Document_TPharm5.xlsx XLSX spreadsheet
Data Pkg 14 Retail Claims with COB.xlsx XLSX spreadsheet
Attachment L-9.5 Non-Formulary List.xlsx XLSX spreadsheet
Data Pkg 5 MOP Utilization by Drug.xlsx XLSX spreadsheet
Data Pkg 25 - OHI Development.xlsx XLSX spreadsheet
Data Pkg 22 - Paid Claims and Rejects - Retail.xlsx XLSX spreadsheet
TPharm5 Draft Section C 20191202.docx DOCX document
Attachment L-5 Guaranty_Agreement.pdf PDF
Data Pkg 6 - MOP Utilization.xlsx XLSX spreadsheet
Attachment L-13 VA_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
Data Pkg 19 Historical_TMDS_Volume_2017-2018.xlsx XLSX spreadsheet
Attachment L-1.1 List of Data Packages.docx DOCX document
Data Pkg 13 - MTF Claims Volumes by Site.xlsx XLSX spreadsheet
TPharm5 Draft Section I 20191120.docx DOCX document
Attachment L-19.1 PPI Tool Instructions.docx DOCX document
Attachment L-9.3 Covered OTCs - Purchased Care.xlsx XLSX spreadsheet
Attachment J-5 TPharm5 Award Fee Plan 20191122.docx DOCX document
TPharm5 Draft Section D 20191120.docx DOCX document
Attachment L-12 IHS_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
TPharm5 Draft Section E 20191120.docx DOCX document
Attachment L-18 CDRL Supplemental Bid Schedule.xlsx XLSX spreadsheet
Data Pkg 7 Specialty Drug Utilization, Retail and Mail.xlsx XLSX spreadsheet
Data Pkg 16 VA_VA CHDR Volume.xlsx XLSX spreadsheet
TPharm5 Draft Section H 20191121.docx DOCX document
Attachment L-7 Teaming Subcontractor Consent Ltr.docx DOCX document
Attachment L-2 Retail Network Reimbursement Table.docx DOCX document
Attachment L-4 Negotiated Specialty Retail Replenished Dispensing Fees.docx DOCX document
Tpharm5 Draft Section G 20191202.docx DOCX document
Data Pkg 10 - Compound Utilizers.xlsx XLSX spreadsheet
TPharm5 Draft Section F 20191202.docx DOCX document
Show 40 more

Latest 50 of 73 listed here. See the rest on GovTribe.

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Sheet1

IDEXTRACT_DATEMANUF_NMNDCNDC_SHORT_DESCRIPTIONNDC_LONG_DESCRIPTIONPV_CDPVONDAPA_HOLDER_NMPRICING_AGREEMENT_NUMPRICING_AGREEMENT_TYPE_CDUNIT_PACKAGEPACKAGE_SIZEUNIT_OF_MEASUREUNIT_PACK_DESCCASE_SIZE_PACKUOM_PRICE_BURDENEDUOM_PRICE_UNBURDENEDUNIT_PRICE_BURDENEDUNIT_PRICE_UNBURDENEDUNIT_OF_SALEUNIT_OF_SALE_QTYPRICE_EFFECTIVE_DATEPRICE_EXPIRATION_DATEGENERIC_SEQUENCE_NUMBRAND_TYPE_CDREPACKAGED_INDDROP_SHIP_ONLY_INDDROP_SHIP_FEE_IND
12019-11-20ELI LILLY00002140701QUINIDINE GLUC 80 MG/ML VIAL 10MLQUINIDINE GLUCONATE 80 MG/ML INJECTION SOLUTION 10MLMCKE1102672MCKESSONVI10MLVIAL OF 10 MILLILITER1EA1000214BNNN
22019-11-20ELI LILLY00002143380TRULICITY 0.75 MG/0.5 ML PEN 0.5MLDULAGLUTIDE 0.75 MG/0.5 ML SUBCUTANEOUS PEN INJECTOR 0.5MLMCKE3292356ELI LILLYSZ0.5MLSYRINGE OF .5 MILLILITER4CT4072872BNNN
32019-11-20ELI LILLY00002143480TRULICITY 1.5 MG/0.5 ML PEN 0.5MLDULAGLUTIDE 1.5 MG/0.5 ML SUBCUTANEOUS PEN INJECTOR 0.5MLMCKE3292372ELI LILLYSZ0.5MLSYRINGE OF .5 MILLILITER4CT4072873BNNN
42019-11-20ELI LILLY00002143611EMGALITY 120 MG/ML PENMLGALCANEZUMAB-GNLM 120 MG/ML SUBCUTANEOUS PEN INJECTORMLMCKE2579894ELI LILLYSZ1MLSYRINGE OF 1 MILLILITER1EA1078996BNNN
52019-11-20ELI LILLY00002144509TALTZ 80 MG/ML AUTOINJ (3-PK)MLIXEKIZUMAB 80 MG/ML SUBCUTANEOUS AUTO-INJECTORMLMCKE3545555ELI LILLYSZ1MLSYRINGE OF 1 MILLILITER3EA3075731BNNN
62019-11-20ELI LILLY00002144511TALTZ 80 MG/ML AUTOINJECTORMLIXEKIZUMAB 80 MG/ML SUBCUTANEOUS AUTO-INJECTORMLMCKE3426954ELI LILLYSZ1MLSYRINGE OF 1 MILLILITER1EA1075731BNNN
72019-11-20ELI LILLY00002144527TALTZ 80 MG/ML AUTOINJ (2-PK)MLIXEKIZUMAB 80 MG/ML SUBCUTANEOUS AUTO-INJECTORMLMCKE3545548ELI LILLYSZ1MLSYRINGE OF 1 MILLILITER2EA2075731BNNN
82019-11-20ELI LILLY00002237711EMGALITY 120 MG/ML SYRINGEMLGALCANEZUMAB-GNLM 120 MG/ML SUBCUTANEOUS SYRINGEMLMCKE3737699ELI LILLYSZ1MLSYRINGE OF 1 MILLILITER1EA1078997BNNN
92019-11-20ELI LILLY00002311509EMGALITY 300 MG (100 MG X3SYR)MLGALCANEZUMAB-GNLM 300 MG/3 ML (100 MG/ML X 3) SUBCUTANEOUS SYRINGEMLMCKE3959889ELI LILLYSZ1MLSYRINGE OF 1 MILLILITER3CT3079818BNNN
102019-11-20ELI LILLY00002322730STRATTERA 10 MG CAPSULE 30SATOMOXETINE 10 MG CAPSULE 30SMCKE2265221ELI LILLYBO30EABOTTLE OF 30 CAPSULE1EA30051489BNNN

File details come from the government source that posted it. Updated .